P&G Adds Merck's Brands, Expands Consumer Health Categories, Footprint

P&G’s planned acquisition of Merck KGaA’s consumer health care business will grow its consumer health portfolio 50%, expand its OTC drug and supplement business abroad and open up new categories.  CEO David Taylor frames the acquisition as another step in the firm's ongoing portfolio shakeup.

Procter & Gamble Co. is taking a sharp turn from trimming its product portfolio and streamlining its operations with an agreement to acquire Merck KGAA's OTC drug and dietary supplement lines, a move that will increase the size of P&G's consumer health business by 50%.

The planned €3.4bn ($4.2bn) all-cash acquisition announced April 19 will extend P&G's consumer health business into new product categories while...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from International

More from Geography